Menu

Latest news & events

Team Science grant Uyen Nguyen and Roel Meiburg

Team Science grant Uyen Nguyen and Roel Meiburg

18 December 2024

Dr Uyen Nguyen (Dept of Cardiology) and Dr Roel Meiburg (Biomedical Engineer, TU Eindhoven) have been awarded a Dekker Team Science grant by the Dutch Heart Foundation.

Read more
ZonMw grant on appropriate palliative care

ZonMw grant on appropriate palliative care

10 December 2024

Prof. Marc Hemmelder (Dept of Internal Medicine) and his team received a ZonMw grant to promote early palliative care for dialysis patients who are non-waitlisted for transplantation.
 

Read more
More newsMore events
Carim Maastricht
Carim Maastricht

Job Verdonschot

Assistant Professor

Dr. Job Verdonschot is a resident at the Clinical Genetics department of the Maastricht UMC+ and an assistant professor at the Cardiology department within CARIM of the Maastricht University.

He finished both a master in biomedical sciences and medicine (cum laude) at the university of Maastricht, with a differentiation in cardiogenetics. In 2016 he received a Kootstra Talent Fellowship to start a PhD investigating the impact of genetic mutations on the clinical course of patients with dilated cardiomyopathy. His PhD thesis received three prizes for best thesis of 2021: by the Dutch association of clinical genetics (VKGN), the Durch association of cardiology (NVVC) and the CARIM research school of the university of Maastricht. In 2021 he started his clinical training to become a clinical geneticist in the Maastricht UMC+ with a differentiation in cardiology and cardiogenetics, which he will finish in 2025, continuing his career as clinical geneticist at the department.

In 2022 he received the prestigious Dekker grant (Clinical Scientist) from the Dutch Heart Foundation to start his research group investigating the impact of genetic mutations for asymptomatic family members. In 2023 and 2024 he also received the Academic Funds and a Veni grant of the NWO to further expand his research line focusing on early detection, improving risk stratification and early treatment, and reproductive options for patients and their family members with a genetic form of dilated cardiomyopathy.

He contributes to multiple national and international committees (for example, he is chair of the national Study Group on family care for cardiomyopathy patients of the National Heart Institute, and leads the writing of international consensus documents on family care and reproductive options from the European Society of Cardiology). He has a strong focus on interdisciplinary collaborations to achieve innovation in health care, depicted by collaboration with the Dutch Forensic Institute (NOFA study funded by ZonMW), the technical University of Eindhoven (as part of the Veni project) and hematology (focusing on clonal hematopoiesis as part of his ERA4HEALTH grant). His goal is to translate research innovations to clinical implementation to improve the care for patients and family members with genetic forms of dilated cardiomyopathy.

Job verdonschot

Department of Cardiology 
Universiteitssingel 50, 6229 ER, Maastricht
P.O. Box 616, 6200 MD Maastricht

Room number: 3.K1.031
T: +31 (0) 43 387 10 98

  • 2024
    • Sikking, M. A., Harding, D., Henkens, M. T. H. M., Stroeks, S. L. V. M., Venner, M. F. G. H. M., Nihant, B., van Leeuwen, R. E. W., Fanti, S., Li, X., van Paassen, P., Knackstedt, C., Brunner-la Rocca, H.-P., van Empel, V. P. M., Verdonschot, J. A. J., Marelli-Berg, F. M., & Heymans, S. R. B. (2024). Cytotoxic T-Cells Drive Outcome in Inflammatory Dilated Cardiomyopathy. Circulation Research, 135(12), 1193-1195. https://doi.org/10.1161/CIRCRESAHA.124.325183
    • Wei, F.-F., Pellicori, P., Ferreira, J. P., González, A., Mariottoni, B., An, D.-W., Verdonschot, J. A. J., Liu, C., Ahmed, F. Z., Petutschnigg, J., Rossignol, P., Heymans, S., Cuthbert, J., Girerd, N., Clark, A. L., Li, Y., Nawrot, T. S., Díez, J., Zannad, F., ... HOMAGE investigators (2024). Effects of spironolactone on exercise blood pressure in patients at increased risk of developing heart failure: report from the HOMAGE trial. Hypertension Research, 47(11), 3225-3236. https://doi.org/10.1038/s41440-024-01843-z
    • Stroeks, S. L. V. M., Henkens, M. T. H. M., Dominguez, F., Merlo, M., Hellebrekers, D. M. E. I., Gonzalez-Lopez, E., Dal Ferro, M., Ochoa, J. P., Venturelli, F., Claes, G. R. F., Venner, M. F. G. H. M., Krapels, I. P. C., Vanhoutte, E. K., van Paassen, P., van den Wijngaard, A., Sikking, M. A., van Leeuwen, R., Abdul Hamid, M., Li, X., ... Verdonschot, J. A. J. (2024). Genetic Landscape of Patients With Dilated Cardiomyopathy and a Systemic Immune-Mediated Disease. JACC: Heart Failure. Advance online publication. https://doi.org/10.1016/j.jchf.2024.08.011
    • Verdonschot, J. A. J., Fuster, J. J., Walsh, K., & Heymans, S. R. B. (2024). The emerging role of clonal haematopoiesis in the pathogenesis of dilated cardiomyopathy. European Heart Journal, Article ehae682. https://doi.org/10.1093/eurheartj/ehae682
    • Verdonschot, J. A. J., Heymans, S. R. B., & Van Linthout, S. (2024). The next era of gene-specific clinical care in patients with dilated cardiomyopathy. European journal of heart failure, 26(10), 2169-2172. https://doi.org/10.1002/ejhf.3446
    • Verdonschot, J. A. J., Paulussen, A. D. C., Lakdawala, N. K., de Die-Smulders, C. E. M., Ware, J. S., & Ingles, J. (2024). Reproductive options and genetic testing for patients with an inherited cardiac disease. Nature Reviews Cardiology. https://doi.org/10.1038/s41569-024-01073-3
    • Yu, Y.-L., Siwy, J., An, D.-W., González, A., Hansen, T., Latosinska, A., Pellicori, P., Ravassa, S., Mariottoni, B., Verdonschot, J. A., Ahmed, F., Petutschnigg, J., Rossignol, P., Heymans, S., Cuthbert, J. J., Girerd, N., Clark, A. L., Verhamme, P., Nawrot, T. S., ... HOMAGE investigators (2024). Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial. Heart, 110(19), 1180-1187. Article heartjnl-2023-323796. https://doi.org/10.1136/heartjnl-2023-323796
    • Gajagowni, S., Hopkins, S., Qadeer, Y., Virani, S. S., Verdonschot, J. A. J., Coombs, C. C., Amos, C. I., Nead, K. T., Jaiswal, S., & Krittanawong, C. (2024). Clonal hematopoiesis of indeterminate potential and cardiovascular disease: Pathogenesis, clinical presentation, and future directions. Progress in Cardiovascular Diseases, 86, 79-85. https://doi.org/10.1016/j.pcad.2024.09.001
    • Wei, F.-F., Mariottoni, B., An, D.-W., Pellicori, P., Yu, Y.-L., Verdonschot, J. A. J., Liu, C., Ahmed, F. Z., Petutschnigg, J., Rossignol, P., Heymans, S., Cuthbert, J., Girerd, N., Li, Y., Clark, A. L., Nawrot, T. S., Ferreira, J. P., Zannad, F., Cleland, J. G. F., ... HOMAGE investigators (2024). Heart rate reactivity, recovery, and endurance of the incremental shuttle walk test in patients prone to heart failure. Esc heart failure, (6). Advance online publication. https://doi.org/10.1002/ehf2.15000
    • Sikking, M. A., & Verdonschot, J. A. J. (2024). How Clonal Hematopoiesis Can Predict Treatment Response in Patients With Dilated Cardiomyopathy. JACC: Basic to Translational Science, 9(8), 968-970. https://doi.org/10.1016/j.jacbts.2024.06.002
    • Beijnink, C. W. H., Raafs, A. G., Vos, J. L., Verdonschot, J. A. J., Sikking, M. A., Rodwell, L., Heymans, S. R. B., & Nijveldt, R. (2024). Papillary Muscle Delayed Hyperenhancement: Prevalence and Clinical Implications in a Large Population With Dilated Cardiomyopathy. JACC: Advances, 3(8), Article 101103. https://doi.org/10.1016/j.jacadv.2024.101103
    • Nihant, B., Verdonschot, J., Heymans, S., Breuer, M., & Adriaens, M. (2024). Computational models of cardiac metabolism reveal distinct metabolic phenotypes in dilated cardiomyopathy patients. European journal of heart failure, 26, 640-641.
    • Wiethoff, I., Sikking, M., Evers, S., Gabrio, A., Henkens, M., Michels, M., Verdonschot, J., Heymans, S., & Hiligsmann, M. (2024). Quality of life and societal costs in patients with dilated cardiomyopathy. European heart journal - Quality of care & clinical outcomes, 10(4), 334-344. Article qcad056. https://doi.org/10.1093/ehjqcco/qcad056
    • Sikking, M. A., Stroeks, S. L. V. M., Henkens, M. T. H. M., Raafs, A. G., Cossins, B., van Deuren, R. C., Steehouwer, M., Riksen, N. P., van den Wijngaard, A., Brunner, H. G., Hoischen, A., Verdonschot, J. A. J., & Heymans, S. R. B. (2024). Clonal Hematopoiesis has Prognostic Value in Dilated Cardiomyopathy independent of Age and Clone Size. JACC: Heart Failure, 12(5), 905-914. https://doi.org/10.1016/j.jchf.2023.06.037
    • Kobayashi, M., Ferreira, J. P., Kevin, D., Bresso, E., Huttin, O., Bozec, E., Brunner La Rocca, H.-P., Delles, C., Clark, A. L., Edelmann, F., González, A., Heymans, S., Pellicori, P., Petutschnigg, J., Verdonschot, J. A. J., Rossignol, P., Cleland, J. G. F., Zannad, F., Girerd, N., & HOMAGE Trial Committees and Investigators (2024). Proteomic profiles of left atrial volume and its influence on response to spironolactone: Findings from the HOMAGE trial and STANISLAS cohort. European journal of heart failure, 26(5), 1231-1241. https://doi.org/10.1002/ejhf.3202
    • Verdonschot, J. A. J., Hellebrekers, D. M. E. I., van Empel, V. P. M., Heijligers, M., de Munnik, S., Coonen, E., Dreesen, J. C. M. F., van den Wijngaard, A., Brunner, H. G., Zamani Esteki, M., Heymans, S. R. B., de Die-Smulders, C. E. M., & Paulussen, A. D. C. (2024). Clinical Guideline for Preimplantation Genetic Testing in Inherited Cardiac Diseases. Circulation: Genomic and Precision Medicine, 17(2), Article E004416. https://doi.org/10.1161/CIRCGEN.123.004416
    • Verdonschot, J. A. J., & Heymans, S. R. B. (2024). Dilated cardiomyopathy: second hits knock-down the heart. European Heart Journal, 45(7), 500-501. https://doi.org/10.1093/eurheartj/ehad778
    • Santos-Ferreira, D., Diaz, S. O., Ferreira, J. P., Girerd, N., Pellicori, P., Mariottoni, B., Cosmi, F., Hazebroek, M., Verdonschot, J. A. J., Cuthbert, J., Petutschnigg, J., Heymans, S., Staessen, J. A., Pieske, B., Edelmann, F., Clark, A. L., Rossignol, P., Fontes-Carvalho, R., Cleland, J. G. F., & Zannad, F. (2024). Phenotyping patients with ischaemic heart disease at risk of developing heart failure: an analysis of the HOMAGE trial. Esc heart failure, 11(1), 209-218. https://doi.org/10.1002/ehf2.14465
    • HENKENS, MICHIEL. T. H. M., RAAFS, ANNE. G., VANLOON, T. I. M., VOS, JACQUELINE. L., VANDENWIJNGAARD, ARTHUR., BRUNNER, HAN. G., KRAPELS, INGRID. P. C., KNACKSTEDT, CHRISTIAN., GERRETSEN, SUZANNE., HAZEBROEK, MARK. R., VERNOOY, KEVIN., NIJVELDT, ROBIN., LUMENS, JOOST., & VERDONSCHOT, JOB. A. J. (2024). Left Atrial Function in Patients with Titin Cardiomyopathy. Journal of Cardiac Failure, 30(1), 51-60. https://doi.org/10.1016/j.cardfail.2023.05.013
  • 2023
    • Hazebroek, M. R., & Verdonschot, J. A. J. (2023). One step closer to the new frontiers of healthcare for cardiomyopathy patients. Heart, 109(24), 1808-1810. https://doi.org/10.1136/heartjnl-2023-323095
    • Sikking, M. A., Stroeks, S. L. V. M., Marelli-Berg, F., Heymans, S. R. B., Ludewig, B., & Verdonschot, J. A. J. (2023). Immunomodulation of Myocardial Fibrosis. JACC: Basic to Translational Science, 8(11), 1477-1488. https://doi.org/10.1016/j.jacbts.2023.03.015
    • Schoonvelde, S. A. C., Ruijmbeek, C. W. B., Hirsch, A., van Slegtenhorst, M. A., Wessels, M. W., von der Thusen, J. H., Baas, A. F., Stroeks, S. L. V. M., Verdonschot, J. A. J., van der Zwaag, P. A., Verhagen, J. M. A., & Michels, M. (2023). Phenotypic Variability of Filamin C-related Cardiomyopathy: Insights from a Novel Dutch Founder Variant. Heart Rhythm, 20(11), 1512-1521. https://doi.org/10.1016/j.hrthm.2023.08.003
    • Raafs, A. G., Adriaans, B. P., Henkens, M. T. H. M., Verdonschot, J. A. J., Abdul Hamid, M. A., Díez, J., Knackstedt, C., van Empel, V. P. M., Brunner-La Rocca, H. P., González, A., Wildberger, J. E., Heymans, S. R. B., & Hazebroek, M. R. (2023). Biomarkers of Collagen Metabolism Are Associated with Left Ventricular Function and Prognosis in Dilated Cardiomyopathy: A Multi-Modal Study. Journal of Clinical Medicine, 12(17), Article 5695. https://doi.org/10.3390/jcm12175695
    • Sikking, M. A., Stroeks, S. L. V. M., Waring, O. J., Henkens, M. T. H. M., Riksen, N. P., Hoischen, A., Heymans, S. R. B., & Verdonschot, J. A. J. (2023). Clonal Hematopoiesis of Indeterminate Potential From a Heart Failure Specialist’s Point of View. Journal of the American Heart Association, 12(15), Article e030603. https://doi.org/10.1161/JAHA.123.030603
    • O'Neill, M. J., Chen, S. N., Rumping, L., Johnson, R., van Slegtenhorst, M., Glazer, A. M., Yang, T., Solus, J. F., Laudeman, J., Mitchell, D. W., Vanags, L. R., Kroncke, B. M., Anderson, K., Gao, S., Verdonschot, J. A. J., Brunner, H., Hellebrekers, D., Taylor, M. R. G., Roden, D. M., ... Shoemaker, M. B. (2023). Multicenter clinical and functional evidence reclassifies a recurrent noncanonical filamin C splice-altering variant. Heart Rhythm, 20(8), 1158-1166. https://doi.org/10.1016/j.hrthm.2023.05.006
    • Kobayashi, M., Huttin, O., Ferreira, J. P., Duarte, K., Gonzalez, A., Heymans, S., Verdonschot, J. A. J., Brunner-La Rocca, H.-P., Pellicori, P. L., Clark, A., Petutschnigg, J., Edelmann, F. G., Cleland, J., Rossignol, P., Zannad, F., Girerd, N., & HOMAGE Trial Committees and Investigators (2023). A machine learning-derived echocardiographic algorithm identifies people at risk of heart failure with distinct cardiac structure, function, and response to spironolactone: findings from the HOMAGE trial. European journal of heart failure, 25(8), 1284-1289. https://doi.org/10.1002/ejhf.2859
    • Stroeks, S. L. V. M., Hellebrekers, D., Claes, G. R. F., Krapels, I. P. C., Henkens, M. H. T. M., Sikking, M., Vanhoutte, E. K., van den Enden, A. T. J. M. H., Brunner, H. G., van den Wijngaard, A., & Verdonschot, J. A. J. (2023). Diagnostic and prognostic relevance of using large gene panels in the genetic testing of patients with dilated cardiomyopathy. European Journal of Human Genetics, 31(7), 776-783. https://doi.org/10.1038/s41431-023-01384-y
    • Sikking, M. A., Stroeks, S. L. V. M., Henkens, M. T. H. M., Venner, M. F. G. H. M., Li, X., Heymans, S. R. B., Hazebroek, M. R., & Verdonschot, J. A. J. (2023). Cardiac Inflammation in Adult-Onset Genetic Dilated Cardiomyopathy. Journal of Clinical Medicine, 12(12), Article 3937. https://doi.org/10.3390/jcm12123937
    • Stroeks, S. L. V. M., & Verdonschot, J. A. J. (2023). The next step toward personalized recommendations for genetic cardiomyopathies. European Journal of Human Genetics, 31(11), 1201 - 1203. https://doi.org/10.1038/s41431-023-01394-w
    • Vermeer, M. C. S. C., Arevalo Gomez, K. F., Hoes, M. F., Tromp, J., Verdonschot, J. A. J., Henkens, M. T. H. M., Silljé, H. H. W., Bolling, M. C., & van der Meer, P. (2023). Clinical Outcome in KLHL24 Cardiomyopathy. Circulation: Genomic and Precision Medicine, 16(4), 401-403. https://doi.org/10.1161/CIRCGEN.122.003998
    • Girerd, N., Levy, D., Duarte, K., Ferreira, J. P., Ballantyne, C., Collier, T., Pizard, A., Björkman, J., Butler, J., Clark, A., Cleland, J. G., Delles, C., Diez, J., González, A., Hazebroek, M., Ho, J., Huby, A. C., Hwang, S. J., Latini, R., ... Zannad, F. (2023). Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study. Circulation-Heart Failure, 16(5), 426-441. Article e009694. https://doi.org/10.1161/CIRCHEARTFAILURE.122.009694
    • Verdonschot, J. A. J., Wang, P., Derks, K. W. J., Adriaens, M. E., Stroeks, S. L. V. M., Henkens, M. T. H. M., Raafs, A. G., Sikking, M., de Koning, B., van den Wijngaard, A., Krapels, I. P. C., Nabben, M., Brunner, H. G., & Heymans, S. R. B. (2023). Clustering of Cardiac Transcriptome Profiles Reveals Unique Subgroups of Dilated Cardiomyopathy Patients. JACC: Basic to Translational Science, 8(4), 406-418. https://doi.org/10.1016/j.jacbts.2022.10.010
    • Stroeks, S. L. V. M., Lunde, I. G. G., Hellebrekers, D. M. E. I., Claes, G. R. F., Wakimoto, H., Gorham, J., Krapels, I. P. C., Vanhoutte, E. K. K., van den Wijngaard, A., Henkens, M. T. H. M., Raafs, A. G. G., Sikking, M. A. A., Broers, J. L. V., Nabben, M., Jones, E. A. V., Heymans, S. R. B., Brunner, H. G. G., & Verdonschot, J. A. J. (2023). Prevalence and Clinical Consequences of Multiple Pathogenic Variants in Dilated Cardiomyopathy. Circulation: Genomic and Precision Medicine, 16(2), Article e003788. https://doi.org/10.1161/CIRCGEN.122.003788
    • Ferreira, J. P., Cleland, J. G. F., Girerd, N., Pellicori, P., Hazebroek, M. R., Verdonschot, J., Collier, T. J., Petutschnigg, J., Clark, A. L., Staessen, J. A., Heymans, S., Rossignol, P., & Zannad, F. (2023). Effect of Spironolactone on QRS Duration in Patients at Risk for Heart Failure (from the HOMAGE Trial). American Journal of Cardiology, 191(1), 39-42. https://doi.org/10.1016/j.amjcard.2022.12.016
    • Stroeks, S. L. V. M., van Beek, D., Adriaens, M. E., & Verdonschot, J. A. J. (2023). Titin Allelic Expression and Protein Processing Pathways in Early-Stage Dilated Cardiomyopathy Patients With Truncating Titin Variants. Circulation: Genomic and Precision Medicine, 16(1), 90-91. Article e003901. https://doi.org/10.1161/circgen.122.003901
    • Ferreira, J. P., Cleland, J. G. F., Girerd, N., Pellicori, P., Hazebroek, M. R., Verdonschot, J., Collier, T. J., Petutschnigg, J., Clark, A. L., Staessen, J. A., Heymans, S., Zannad, F., & Rossignol, P. (2023). Early and late renal function changes with spironolactone in patients at risk of developing heart failure: findings from the HOMAGE trial. Clinical research in cardiology, 112(2), 330-332. https://doi.org/10.1007/s00392-022-02116-w
    • Nuzzi, V., Raafs, A., Manca, P., Henkens, M. T. H. M., Gregorio, C., Boscutti, A., Verdonschot, J., Hazebroek, M., Knackstedt, C., Merlo, M., Stolfo, D., Sinagra, G., & Heymans, S. R. B. (2023). Left Atrial Reverse Remodeling in Dilated Cardiomyopathy. Journal of the American Society of Echocardiography, 36(2), 154-162. https://doi.org/10.1016/j.echo.2022.10.017
    • van Beek, D., Verdonschot, J., Derks, K., Brunner, H., de Kok, T., Arts, I., Heymans, S., Kutmon, M., & Adriaens, M. (2023). Allele-specific expression analysis for complex genetic phenotypes applied to a unique dilated cardiomyopathy cohort. Scientific Reports, 13(1), Article 564. https://doi.org/10.1038/s41598-023-27591-7
  • 2022
    • Hurkmans, E. G. E., Brand, A. C. A. M., Verdonschot, J. A. J., Te Loo, D. M. W. M., & Coenen, M. J. H. (2022). Pharmacogenetics of chemotherapy treatment response and -toxicities in patients with osteosarcoma: a systematic review. BMC Cancer, 22(1), 1326. Article 1326. https://doi.org/10.1186/s12885-022-10434-5
    • Raafs, A. G., Henkens, M. T. H. M., Vos, J. L., Nijveldt, R., & Verdonschot, J. A. J. (2022). REPLY: Further Insights Into the Prognostic Value of Left Atrial Strain in Dilated Cardiomyopathy?JACC-Cardiovascular Imaging, 15(12), 2156-2157. https://doi.org/10.1016/j.jcmg.2022.09.017
    • Leitao, E., Schroder, C., Parenti, I., Dalle, C., Rastetter, A., Kuhnel, T., Kuechler, A., Kaya, S., Gerard, B., Schaefer, E., Nava, C., Drouot, N., Engel, C., Piard, J., Duban-Bedu, B., Villard, L., Stegmann, A. P. A., Vanhoutte, E. K., Verdonschot, J. A. J., ... Depienne, C. (2022). Systematic analysis and prediction of genes associated with monogenic disorders on human chromosome X. Nature Communications, 13(1), Article 6570. https://doi.org/10.1038/s41467-022-34264-y
    • Lota, A. S., Hazebroek, M. R., Theotokis, P., Wassall, R., Salmi, S., Halliday, B. P., Tayal, U., Verdonschot, J., Meena, D., Owen, R., de Marvao, A., Iacob, A., Yazdani, M., Hammersley, D. J., Jones, R. E., Wage, R., Buchan, R., Vivian, F., Hafouda, Y., ... Prasad, S. K. (2022). Genetic Architecture of Acute Myocarditis and the Overlap with Inherited Cardiomyopathy. Circulation, 146(15), 1123-1134. https://doi.org/10.1161/CIRCULATIONAHA.121.058457
    • de Frutos, F., Ochoa, J. P., Navarro-Peñalver, M., Baas, A., Bjerre, J. V., Zorio, E., Méndez, I., Lorca, R., Verdonschot, J. A., García-Granja, P. E., Bilinska, Z., Fatkin, D., Fuentes-Cañamero, M. E., García-Pinilla, J. M., García-Álvarez, M. I., Girolami, F., Barriales-Villa, R., Díez-López, C., Lopes, L. R., ... European Genetic Cardiomyopathies Initiative Investigators (2022). Natural History of MYH7-related Dilated Cardiomyopathy. Journal of the American College of Cardiology, 80(15), 1447-1461. https://doi.org/10.1016/j.jacc.2022.07.023
    • Raafs, A. G., Adriaans, B. P., Henkens, M. T. H. M., Verdonschot, J. A. J., Ramaekers, M. J. F. G., Gommers, S., Hamid, M. A. A., Schalla, S., Knackstedt, C., van Empel, V. P. M., Hans-Peter, B., Wildberger, J. E., Bekkers, S. C. A. M., & Hazebroek, M. R. (2022). Myocardial Fibrosis Assessment Using T1 and ECV Mapping With Histologic Validation in Chronic Dilated Cardiomyopathy. JACC-Cardiovascular Imaging, 15(10), 1828-1830. https://doi.org/10.1016/j.jcmg.2022.05.002
    • Escobar-Lopez, L., Ochoa, J. P., Royuela, A., Verdonschot, J. A. J., Dal Ferro, M., Espinosa, M. A., Sabater-Molina, M., Gallego-Delgado, M., Larrañaga-Moreira, J. M., Garcia-Pinilla, J. M., Basurte-Elorz, M. T., Rodríguez-Palomares, J. F., Climent, V., Bermudez-Jimenez, F. J., Mogollón-Jiménez, M. V., Lopez, J., Peña-Peña, M. L., Garcia-Alvarez, A., López-Abel, B., ... Garcia-Pavia, P. (2022). Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated Cardiomyopathy. Journal of the American College of Cardiology, 80(12), 1115-1126. https://doi.org/10.1016/j.jacc.2022.06.040
    • Kobayashi, M., Girerd, N., Ferreira, J. P., Kevin, D., Huttin, O., Gonzalez, A., Bozec, E., Clark, A. L., Cosmi, F., Cuthbert, J., Diez, J., Edelmann, F., Hazebroek, M., Heymans, S., Mariottoni, B., Pellicori, P., Petutschnigg, J., Pieske, B., Staessen, J. A., ... HOMAGE Trial Committees (2022). The association between markers of type I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from the HOMAGE trial. European journal of heart failure, 24(9), 1559-1568. https://doi.org/10.1002/ejhf.2579
    • Henkens, M. T. H. M., Stroeks, S. L. V. M., Raafs, A. G., Sikking, M. A., Tromp, J., Ouwerkerk, W., Hazebroek, M. R., Krapels, I. P. C., Knackstedt, C., van den Wijngaard, A., Brunner, H. G., Heymans, S. R. B., & Verdonschot, J. A. J. (2022). Dynamic Ejection Fraction Trajectory in Patients With Dilated Cardiomyopathy With a Truncating Titin Variant. Circulation-Heart Failure, 15(8), Article e009352. https://doi.org/10.1161/CIRCHEARTFAILURE.121.009352
    • Willemars, M. M. A., Nabben, M., Verdonschot, J. A. J., & Hoes, M. F. (2022). Evaluation of the Interaction of Sex Hormones and Cardiovascular Function and Health. Current Heart Failure Reports, 19(4), 200-212. https://doi.org/10.1007/s11897-022-00555-0
    • Henkens, M. T. H. M., Martinez, H. L., Weerts, J., Sammani, A., Raafs, A. G., Verdonschot, J. A. J., van de Leur, R. R., Sikking, M. A., Stroeks, S., van Empel, V. P. M., Brunner-La Rocca, H. P., van Stipdonk, A. M. W., Farmakis, D., Hazebroek, M. R., Vernooy, K., Bayes-de-Luna, A., Asselbergs, F. W., Bayes-Genis, A., & Heymans, S. R. B. (2022). Interatrial Block Predicts Life-Threatening Arrhythmias in Dilated Cardiomyopathy. Journal of the American Heart Association, 11(14), Article e025473. https://doi.org/10.1161/JAHA.121.025473
    • Tayal, U., Verdonschot, J. A. J., Hazebroek, M. R., Howard, J., Gregson, J., Newsome, S., Gulati, A., Pua, C. J., Halliday, B. P., Lota, A. S., Buchan, R. J., Whiffin, N., Kanapeckaite, L., Baruah, R., Jarman, J. W. E., O'Regan, D. P., Barton, P. J. R., Ware, J. S., Pennell, D. J., ... Prasad, S. K. (2022). Precision Phenotyping of Dilated Cardiomyopathy Using Multidimensional Data. Journal of the American College of Cardiology, 79(22), 2219-2232. https://doi.org/10.1016/j.jacc.2022.03.375
Overview